<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03306784</url>
  </required_header>
  <id_info>
    <org_study_id>RC17_0182</org_study_id>
    <nct_id>NCT03306784</nct_id>
  </id_info>
  <brief_title>Pain Catastrophizing and Routine Assessment of Patient Index Data 3(RAPID3) in Ten Categories of Rheumatology Outpatients</brief_title>
  <official_title>Transversal Study of Correlations Between Pain Catastrophizing Scale (PCS) and RAPID3 Score According to Ten Categories of Conditions Seen in an Outpatient Rheumatology Clinic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fulfilling by all patients consequently seen by 6 rheumatologists in a same outpatient&#xD;
      rheumatology clinic (in at least one month period) of a set of 6 questionnaires, including&#xD;
      RAPID3 and pain catastrophizing scales.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fulfilling by all patients (seen by 6 rheumatologists in a same outpatient rheumatology&#xD;
      clinic from a university French hospital in at least one month period) of a set of 6&#xD;
      questionnaires including a RAPID3 score (Routine Assessment of Patient Index Data 3) and pain&#xD;
      catastrophizing scale, as well as Pain detect and Hospital Anxiety and Depression scale&#xD;
      questionnaires (HAD) , in ten predefined categories of disorders: rheumatoid arthritis; any&#xD;
      spondyloarthritis; other inflammatory rheumatisms or systemic disorders; osteoarthritis of&#xD;
      the upper part of the body; osteoarthritis of the lower part of the body; back pain and/or&#xD;
      radiculalgia; bone disorders, including osteoporosis; tendinosis and other soft tissue&#xD;
      conditions; peripheral neuropathy, including entrapment neuropathies; fibromyalgia and&#xD;
      related conditions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 3, 2017</start_date>
  <completion_date type="Actual">January 31, 2018</completion_date>
  <primary_completion_date type="Actual">January 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ranking of PCS scores according to the underlying disorders (10 predefined categories), and also ranking of RAPID-3 scores according to the underlying disorders (10 predefined categories).</measure>
    <time_frame>At least one month for each physician, and at least 30 patients in each category (whatever the physician seen).</time_frame>
    <description>Composite score: RAPID3 (0-30) and PCS (0-52) are widely used scales, suitable for routine fulfillment by outpatients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ranking of correlations between RAPID3 and Pain catastrophizing scale (PCS) (13 items) scores in the 10 subsets of categories listed above (from the strongest correlation to the lowest correlation)</measure>
    <time_frame>At least one month for each physician, and at least 30 patients in each category (whatever the physician seen).</time_frame>
    <description>RAPID3 (0-30) and PCS (0-52) are widely used scales, suitable for routine fulfillment by outpatients</description>
  </secondary_outcome>
  <enrollment type="Actual">572</enrollment>
  <condition>Arthritis, Rheumatoid</condition>
  <condition>Spondyloarthritis</condition>
  <condition>Inflammatory Rheumatisms</condition>
  <condition>Systemic Disorders</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaires</intervention_name>
    <description>questionnaires, including RAPID3 and pain catastrophizing scales</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        300 Men or women coming to the Rheumatology Department of the Nantes University Hospital&#xD;
        with a senior rheumatologist agreeing to fulfil the set of 6 questionnaires&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  any outpatient aged 18 or more, agreeing to fulfil the set of 6 questionnaires&#xD;
&#xD;
          -  Man or woman coming to the Rheumatology Department of the Nantes University Hospital&#xD;
             with a senior rheumatologist&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients not fluent enough in French or suffering from neurological or psychological&#xD;
             disorders making their responses unreliable&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Marie Berthelot, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nantes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 5, 2017</study_first_submitted>
  <study_first_submitted_qc>October 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2017</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>RAPID3</keyword>
  <keyword>pain catastrophizing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rheumatic Fever</mesh_term>
    <mesh_term>Spondylarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Rheumatic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

